Healthcare | July 11, 2023
Bausch + Lomb acquires Blink eye drops
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Advances clinical research capabilities with leading regulatory grade registries platform
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Subscribe To Our Newsletter & Stay Updated
